Update Alert 2: Remdesivir for Adults With COVID-19
- 1 December 2021
- journal article
- letter
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 174 (12), W114-W115
- https://doi.org/10.7326/l21-0600
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19Annals of Internal Medicine, 2021
- Update Alert: Remdesivir for Adults With COVID-19Annals of Internal Medicine, 2021
- Major Update: Remdesivir for Adults With COVID-19Annals of Internal Medicine, 2021
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial ResultsThe New England Journal of Medicine, 2021
- Remdesivir for Adults With COVID-19Annals of Internal Medicine, 2021
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19The New England Journal of Medicine, 2020
- Remdesivir for the Treatment of Covid-19 — Final ReportThe New England Journal of Medicine, 2020
- Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19JAMA, 2020
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trialThe Lancet, 2020